Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-789
Closed -$53K 4093
2020
Q1
$53K Buy
789
+50
+7% +$5.04K ﹤0.01% 3899
2019
Q4
$103K Sell
739
-293
-28% -$38K ﹤0.01% 4065
2019
Q3
$108K Buy
+1,032
New +$103K ﹤0.01% 3958
2018
Q3
Sell
-508
Closed -$213K 3929
2018
Q2
$213K Buy
+508
New +$171K ﹤0.01% 3749

Other funds holding OPTN

Credit Suisse's OPTN Position: Q2 2020 in Review

Credit Suisse sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 789 shares — an estimated $53K sold.

Credit Suisse first reported a position in OPTN in Q2 2018 and held it in 4 quarters. The position peaked at $213K in Q2 2018. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

  • Credit Suisse reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
  • Credit Suisse sold 789 OptiNose shares in Q2 2020, an estimated $53K.
  • Credit Suisse first reported a position in OptiNose in Q2 2018 and held it in 4 quarters.
  • Credit Suisse's OptiNose position peaked at $213K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.